NCT01804634 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT01804634
Title	Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Recruitment	Recruiting
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Indications	Advanced Solid Tumor
Therapies	Cyclophosphamide + Fludarabine + Melphalan + Sirolimus
Age Groups:	adult \| child
Covered Countries	USA

Filter rows:

Showing 1 to 4 of 4 entries

Facility	Status	City	State	Zip	Country	Details
Albert Einstein College of Medicine, Children's Hospital at Montefiore	RECRUITING	Bronx	New York	10467	United States	Details
Johns Hopkins All Children's Hospital	ACTIVE_NOT_RECRUITING	Saint Petersburg	Florida	33701	United States	Details
New York Medical Center/ Maria Fareri Children's Hospital	RECRUITING	Valhalla	New York	10595	United States	Details
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	RECRUITING	Baltimore	Maryland	21231	United States	Details

Showing 1 to 4 of 4 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT01804634Clinical Trial Detail